Sample-to-answer system for microorganism detection featuring target enrichment, amplification and detection

US11214823B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11214823-B2
Application numberUS-201615389372-A
CountryUS
Kind codeB2
Filing dateDec 22, 2016
Priority dateDec 22, 2015
Publication dateJan 4, 2022
Grant dateJan 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to sample-to-answer systems, devices, cartridges, and method of using the same for detecting the presence of microorganisms in a sample, such as bacteria.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for analyzing a biological sample for the presence of a target of interest, the method comprising: providing a cartridge, wherein the cartridge comprises a sample chamber, a waste chamber, and at least one reaction chamber, wherein fluidic communication between the sample chamber, waste chamber and at least one reaction chamber is provided by one or more microfluidic channels; adding the biological sample to the sample chamber comprising a filter; enriching the biological sample; wherein the step of enriching the sample comprises: (a) filtering the biological sample through the filter in the sample chamber, wherein fluid passed through the filter is stored in a waste chamber and the remainder of the biological sample remains in the sample chamber; or, (b) magnetically labeling the targets of interest within the sample and subjecting the labelled sample to a magnetic field; washing the sample by releasing a washing fluid into the sample chamber; drawing the washing fluid through the filter by applying positive or negative pressure, wherein the washing fluid passed through the filter is stored in the waste chamber; releasing a lysis fluid into the sample chamber; producing a lysate by (a) applying heat to the filter and the biological sample or by (b) subjecting the biological sample to an electric field to cause electroporation; moving the lysate to the at least one reaction chamber by applying positive or negative pressure to the microfluidic channel; applying heat to the at least one reaction chamber; performing a reaction in the at least one reaction chamber; and monitoring the at least one reaction chamber to determine whether the target of interest is present in the biological sample. 2. The method of claim 1 , wherein a magnetic field is created using a solenoid. 3. The method of claim 1 , wherein the electric field is applied to a sample as it travels through a channel to the reaction chamber. 4. The method of claim 1 , wherein the steps of adding a sample to a filter through obtaining a lysate comprises using a spin column filtration configuration or a syringe based cartridge. 5. The method of claim 1 , wherein the method additionally includes prewetting the filter. 6. The method of claim 5 , wherein prewetting comprises releasing a prewetting fluid. 7. The method of claim 5 , wherein washing the sample comprises releasing a washing fluid. 8. The method of claim 5 wherein the sample is held in a first portion of the sample chamber until prewetting the filter occurs. 9. The method of claim 5 wherein a check valve is present in the sample chamber to separate the first portion of the chamber from a second portion. 10. The method of claim 9 , wherein the second portion of the sample chamber contains the filter. 11. The method of claim 1 , wherein the target of interest is selected from the group consisting of: Trichomonas vaginalis, Chlamytha trachomatis , and Neisseria gonorrhoeae. 12. The method of claim 1 , wherein a sample processing control is additionally provided in the sample chamber with the biological sample. 13. The method of claim 1 , wherein the biological sample is selected from the group consisting of: bronchoalveolar lavage, urine, blood, saliva, cerebrospinal fluid, endocervical, vaginal, buccal, nasal, tears, serum, plasma, biopsy sample, skin, stool, sweat, synovial fluid, wound fluid, dental scraping, and penile swab. 14. The method of claim 13 , wherein the biological sample is a urine sample. 15. The method of claim 6 , wherein the prewetting liquid is released by crushing a blister pack, or by using a plunger to burst a blister pack. 16. The method of claim 6 , wherein the prewetting liquid is water. 17. The method of claim 1 , wherein the biological sample is released for filtering by application of a negative pressure below a check valve crack pressure. 18. The method of claim 1 , wherein the biological sample is filtered through the filter using a negative pressure from downstream of the filter. 19. The method of claim 1 , wherein the biological sample is filtered through the filter using a positive pressure from upstream of the filter. 20. The method of claim 1 , wherein a negative pressure is used to draw the washing liquid through the filter. 21. The method of claim 1 , wherein the washing liquid is water. 22. The method of claim 1 , wherein the lysis liquid is released onto the filter by crushing a blister pack or by using a plunger to burst a blister pack. 23. The method of claim 15 or 22 wherein the blister pack contains a frangible seal. 24. The method of claim 1 , wherein at least one resistive heater are used to rapidly heat the filter and lyse the bacteria in the biological sample. 25. The method of claim 24 , wherein the at least one resistive heater is attached to a heat block. 26. The method of claim 25 , wherein the heat block is configured to have the same interior shape as the outer shape of the sample chamber. 27. The method of claim 1 , wherein the lysate is drawn past a first Y-branch separating waste from reaction chambers. 28. The method of claim 27 , wherein the lysate is drawn past a second Y-branch separating the lysate into at least one measured portions for at least one reaction. 29. The method of claim 1 , wherein the lysate is dispensed into at least one reaction chamber. 30. The method of claim 29 , wherein the reaction chamber contains dried reagents. 31. The method of claim 30 wherein the reaction chamber is heated to mix the dispensed lysate and the dried reagent. 32. The method of claim 29 , wherein the at least one reaction chamber fills until a hydrophobic valve is sealed, corresponding to a desired reaction volume. 33. The method of claim 31 , wherein heat is applied by a Peltier device. 34. The method of claim 1 , wherein the reaction performed in the reaction chamber is an amplification reaction. 35. The method of claim 34 , wherein the amplification reaction is PCR. 36. The method of claim 35 , wherein monitoring the at least one reaction chamber comprises monitoring the reaction chamber for a detectable property. 37. The method of claim 36 , wherein the detectable property is fluorescence. 38. The method of claim 37 , wherein a fluorescence signal is monitored during a PCR reaction using two color channels. 39. The method of claim 38 , wherein at least one color channel is used for a control signal. 40. The method of claim 38 , wherein a quantification cycle is determined for each color and compared to cutoffs to return results for each assay. 41. The method of claim 12 , wherein monitoring the reaction chamber for the sample processing control will confirm whether the sample has been captured and lysed. 42. The method of claim 41 , wherein the sample processing control is selected from a dried micro-organism, a plasmid construct, or polynucleotide. 43. The method of claim 42 , wherein the sample processing control is a human cell or DNA sequence. 44. A method for analyzing a biological sample for the presence

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11214823B2 cover?
The present invention relates to sample-to-answer systems, devices, cartridges, and method of using the same for detecting the presence of microorganisms in a sample, such as bacteria.
Who is the assignee on this patent?
Canon Usa Inc
What technology area does this patent fall under?
Primary CPC classification B01L3/502. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).